Home People Howard Eisen – Biography, Age, Medical Education, Career & Net Worth

Howard Eisen – Biography, Age, Medical Education, Career & Net Worth

Howard Eisen (born May 1956) is a board-certified American cardiologist in Hershey, Pennsylvania. He subspecializes in adult congenital heart disease and heart failure and transplantation.

Howard Eisen

Howard Eisen Facts

  • Full Name: Howard Joel Eisen
  • Age: 66 years old
  • Date of Birth: May 1956
  • Place of Birth: Queens, New York City
  • Occupation: Cardiologist
  • Nationality: American

Howard Eisen Medical School & Residency

  • Washington University/B-JH/SLCH Consortium – Fellowship, Cardiovascular Disease
  • University of Pennsylvania Health System – Residency, Internal Medicine
  • University of Pennsylvania Health System – Internship, Internal Medicine, 1981-1982
  • Perelman School of Medicine at the University of Pennsylvania – Medical School

Howard Eisen Career

From 1987 until 1993, he served as Director of Nuclear Cardiology, Medical Co-Director of the Cardiac Transplant Program, and Assistant Professor of Medicine and Radiology in the Cardiology Division at the University of Pennsylvania. In 1993, Dr. Eisen was appointed Medical Director of the Advanced Heart Failure and Cardiac Transplant Programs and Professor of Medicine and Physiology at Temple University School of Medicine in Philadelphia, Pennsylvania.

At Temple. Dr. Eisen directed the largest cardiac transplant program in the United States and was a leader of the everolinus clinical trial published in the New England Journal of Medicine. He also served as a leader for the Neoral, MMF, Myfortic, and photopheresis cardiac transplant clinical trials, as well as the CARGO I study. Dr. Eisen was recruited in 2005 to serve as Chief of the Cardiology Division at Drexel University College of Medicine and Hahnemann Hospital in Philadelphia, Pennsylvania.

He was the Joseph DiPalma MD Family Professor of Cardiology and the Thomas J. Vischer Professor of Medicine in the College of Medicine of Drexel University. He directed the largest clinical trial involving heart transplant patients, the everolimus versus MMF clinical trial. Dr. Eisen continues to conduct research on heart failure, cardiac transplantation, and mechanical circulatory support, as well as treat patients with these conditions.

He has been appointed to the ISHLT Board of Directors. Dr. Eisen has served as a grant reviewer for the National Institutes of Health, the National Heart, Lung, and Blood Institute, and the American Heart Association. He has been recognized by Castle-Connolly and Philadelphia Magazine as a Top Doctor and a Best Doctor in the United States, respectively.

In addition, he is one of the top 27 cardiologists on the Forbes Honor Roll of Cardiologists and the only one from Pennsylvania. Recently, he was inducted into the Association of University Cardiologists. Currently, he is tenured Professor of Medicine and Medical Director of the Cardiac Transplant, MCS, and Advanced Heart Failure Programs as well as Diagnostic Cardiology at the Penn State University College of Medicine/Milton S. Hershey Medical Center.

Certifications & Licensure

  • American Board of Internal Medicine – Certified in Advanced Heart Failure and Transplant Cardiology
  • American Board of Internal Medicine – Certified in Cardiovascular Disease
  • American Board of Internal Medicine – Certified in Internal Medicine
  • PA State Medical License – Active through 2022
  • NJ State Medical License – Active through 2023
  • MD State Medical License – Active through 2022

Hospital Affiliations

  • Penn State Health Milton S. Hershey Medical Center, Hershey, PA

Specialty Expertise

Dr. Howard Joel Eisen has the following 10 areas of expertise

  • Heart Failure
  • High Blood Pressure (Hypertension)
  • High Cholesterol (Hypercholesterolemia)
  • Heart Disease (Myocardial Ischemia)
  • Myocardial Infarction
  • Heart Transplantation
  • Unstable Angina
  • Acute Coronary Syndrome (ACS)
  • Heart Block
  • Heart Diseases

Insurance Accepted

  • Aetna Choice POS II
  • Aetna Choice POS Open Access
  • Aetna HMO
  • Aetna Managed Choice POS Open Access
  • Aetna Select
  • Aetna Signature Administrators PPO
  • Amerihealth Regional Pref Ntwk EPO POS + PPO
  • Amerihealth Regional Pref Ntwk HMO HMO + POS
  • BCBS Blue Card PPO
  • Capital BC PPO
  • CIGNA Open Access Plus
  • Coventry DE PPO
  • Coventry HealthAmerica HMO
  • Coventry HealthAmerica PPO
  • First Health PPO
  • Highmark Alliance Flex Blue
  • Highmark Blue Cross Blue Shield Shared Cost 1500, a Multi-State Plan
  • Highmark Community Blue Flex EPO
  • Highmark Community Blue PPO
  • Highmark Comprehensive Care Blue PPO 1500 MRF
  • Highmark Comprehensive Care Flex Blue PPO 500 MRF
  • Highmark Health Savings Blue PPO 1400 MRF
  • Highmark Shared Cost Blue PPO 6000 MRF
  • Horizon Direct Access
  • Horizon HMO
  • Horizon OMNIA
  • Horizon POS
  • Horizon PPO
  • Humana Choice POS
  • Humana ChoiceCare Network PPO
  • IBC Keystone HMO POS
  • IBC Personal Choice PPO
  • Multiplan PPO
  • Oxford Freedom
  • Oxford Liberty
  • UHC Choice Plus POS
  • UHC Navigate HMO
  • UHC Navigate POS
  • UHC Options PPO

Location & Contact Information

Center For Advance Heart Care
230 N Broad St Ste 742
Philadelphia, PA 19102
(215) 762-4200

Fax: (215) 576-2457
Website: hahnemannhospital.edu

University Cardiology Physicians
245 N 15th St Fl 6 # 6617
Philadelphia, PA 19102
(215) 762-7000

Fax:(215) 576-2755

Expert Publications

Data provided by the National Library of Medicine

  • Noninvasive detection of cardiac transplant rejection using electronic monitoring.
  • Tolerability of extended duration intravenous milrinone in patients hospitalized for advanced heart failure and the usefulness of uptitration of oral angiotensin-converting enzyme inhibitors.
  • Comparison of oxygen therapy with nasal continuous positive airway pressure on Cheyne-Stokes respiration during sleep in congestive heart failure.
  • Quantitative assessment of cell adhesion molecule gene expression in endomyocardial biopsy specimens from cardiac transplant recipients using competitive polymerase chain reaction.
  • Feasibility of photopheresis to reduce the occurrence of restenosis after percutaneous transluminal coronary angioplasty: a clinical pilot study.
  • Letter: Disulfiram hepatotoxicity.
  • Allograft inflammatory factor-1 expression correlates with cardiac rejection and development of cardiac allograft vasculopathy.
  • Effects of nasal continuous positive airway pressure on oxygen body stores in patients with Cheyne-Stokes respiration and congestive heart failure.
  • Hypertension in heart transplant recipients: more than just cyclosporine.
  • Adverse outcomes from the use of older donor hearts in cardiac transplant recipients: the pros and cons of expanded donor criteria.
  • Early growth responsive gene (Egr)-1 expression correlates with cardiac allograft rejection.
  • Effect of older donor age on risk for mortality after heart transplantation.
  • Expression of the FAST-1 transcription factor in coronary artery transplant vasculopathy and activated vascular smooth muscle cells.
  • Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients.
  • Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up.

Awards and Recognition

  • 1979 – Alpha Omega Alpha (University of Pennsylvania School of Medicine)
  • 1981 – Pincus Prize for Outstanding Achievement as a Clinician, University of Pennsylvania School of Medicine
  • 1989 – Louis R. Dinon Teaching Award (presented by Medical Student Body – University of Pennsylvania)
  • 1993 – Henry Christian Award for Excellence in Research, American Federation for Clinical Research-Cardiobiology       (Senior Investigator)
  • 1993 – Henry Christian Award for Excellence in Research, American Federation for Clinical Research-Immunology (First Author and Senior Investigator)
  • 1993 – The Donna K. McCurdy Teaching Award, Department of Medicine, University of Pennsylvania
  • 1996 – Established Investigatorship, American Heart Association National Center
  • 1996-Present – Listed as one of “Top Doctors” in Philadelphia by Philadelphia Magazine
  • 1998-Present – Listed in Best Doctors in America
  • 1998-Present – Listed in Castle-Connolly Top Doctors in America
  • 2003 – American Heart Association Southeastern Pennsylvania All- Around Champion Award
  • 2012 and 2013 – Keynote Speaker, Sejong General Hospital Cardiovascular Symposium. Seoul, South Korea
  • 2012-Present – Listed as a Super Doctor by Superdoctors.com
  • 2015 – Keynote Speaker, Spanish Transplantation Society, Santander, Spain
  • 2016 – Smith-Oliver Society Alumni Visiting Professor, Division of Cardiology. Washington University School of Medicine,       St. Louis, Missouri
  • 2017 – Selected to be on Forbes’ Cardiologists Honor Roll (one of 27 in the nation and the only one in Philadelphia and Pennsylvania)

Howard Eisen Net Worth

Howard Eisen has an estimated net worth of $7 million.


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.